Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
ATOS
— Atossa Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2024 Earnings Call Summary
MAR 25, 2025
REVENUE
$0
EPS
-$0.75
+12.9%
FREE CASH FLOW
-$7.1M
-48.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →